K.J. Harrison & Partners’s Bristol-Myers Squibb BMY Stock Holding History

K.J. Harrison & Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$520K	Buy	+9,017	New	+$518K	0.07%	167
2026 Q1	–	Sell	-10,017	Closed	-$540K	–	234
2025 Q4	$540K	Buy	+10,017	New	+$482K	0.07%	173
2024 Q4	–	Sell	-20,500	Closed	-$1.07M	–	198
2024 Q3	$1.07M	Buy	+20,500	New	+$962K	0.16%	128
2021 Q4	–	Sell	-13,420	Closed	-$799K	–	385
2021 Q3	$799K	Hold	13,420	–	–	0.12%	171
2021 Q2	$898K	Hold	13,420	–	–	0.09%	167
2021 Q1	$847K	Hold	13,420	–	–	0.13%	162
2020 Q4	$832K	Buy	13,420 +1,600	+14%	+$98.4K	0.14%	168
2020 Q3	$713K	Hold	11,820	–	–	0.15%	142
2020 Q2	$695K	Sell	11,820 -500	-4%	-$29.9K	0.19%	116
2020 Q1	$687K	Buy	12,320 +2,320	+23%	+$142K	0.38%	67
2019 Q4	$642K	Hold	10,000	–	–	0.16%	123
2019 Q3	$507K	Sell	10,000 -3,000	-23%	-$141K	0.14%	119
2019 Q2	$590K	Sell	13,000 -11,000	-46%	-$512K	0.19%	103
2019 Q1	$1.15M	Buy	+24,000	New	+$1.2M	0.4%	77
2016 Q4	–	Sell	-4,500	Closed	-$243K	–	203
2016 Q3	$243K	Buy	+4,500	New	+$289K	0.12%	176

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

K.J. Harrison & Partners's BMY Position: Q2 2026 in Review

K.J. Harrison & Partners opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 9,017 shares worth $520K. The stake represents 0.07% of the portfolio and ranks #167 among its holdings. This is a return to the name: K.J. Harrison & Partners previously reported a position in BMY as recently as Q4 2025.

K.J. Harrison & Partners first reported a position in BMY in Q3 2016 and has held it in 15 quarters since. The position peaked at $1.15M in Q1 2019. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

K.J. Harrison & Partners held 9,017 shares of Bristol-Myers Squibb worth $520K as of Q2 2026.
Bristol-Myers Squibb was a new K.J. Harrison & Partners position in Q2 2026.
Bristol-Myers Squibb made up 0.07% of K.J. Harrison & Partners's portfolio in Q2 2026, its #167 holding.
K.J. Harrison & Partners first reported a position in Bristol-Myers Squibb in Q3 2016 and has held it in 15 quarters since.
K.J. Harrison & Partners's Bristol-Myers Squibb position peaked at $1.15M in Q1 2019.
2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on K.J. Harrison & Partners's 13F filing for Q2 2026, filed 7 Aug 2026.